Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study - Wikidata - wikimedia - TriplyDB

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study

http://www.wikidata.org/entity/Q33377664

about

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.Experimental approaches for the treatment of malignant gliomas.Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.Topoisomerase I inhibitors for the treatment of brain tumors.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.

P2860

Q33382342-3489378E-D6BE-4430-BF4A-342458D05F8A Q33713587-DAA78168-942A-4F96-B2C2-A985882F2979 Q34127138-7AEB1A0D-7CED-4EB0-8E31-9AF7E2A8CAB3 Q36113188-CDB606E4-77B6-440C-B382-02E3D3D42779 Q37159504-20BC2DF5-E192-4F3D-A156-8CA909794745 Q37731433-E77374A5-7737-4F1B-AF51-5BC98FA0C544 Q41287854-09E3B563-409E-435A-96FE-8140B5C4FC54

P2860

Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study

http://www.wikidata.org/entity/Q33377664

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Phase I study of temozolomide ...... n brain tumor consortium study

@ast

Phase I study of temozolomide ...... n brain tumor consortium study

@en

type

label

Phase I study of temozolomide ...... n brain tumor consortium study

@ast

Phase I study of temozolomide ...... n brain tumor consortium study

@en

prefLabel

Phase I study of temozolomide ...... n brain tumor consortium study

@ast

Phase I study of temozolomide ...... n brain tumor consortium study

@en

P1433

Q33377664-D2A1240F-C825-41BF-B907-2708677EB7FA

P1476

Q33377664-ADB82740-6240-4085-8E36-CADEA905E931

P2093

Q33377664-0184D87C-07AB-4192-A0A3-823364CE11AF

Q33377664-099CC5B4-D8A3-42C2-887A-88FF7BDA4923

Q33377664-280A98C6-928E-4F41-BC3A-B177748D4ABD

Q33377664-32BB22B3-0264-48F3-8574-D48833CB678D

Q33377664-534CB4AA-CBF6-4EB5-8B6E-0A48AE19FEE9

Q33377664-57AF22F6-2D55-4E68-94E1-473E69FF4B35

Q33377664-716ED328-1891-4011-8FED-BC299719F8A5

Q33377664-7F67C1D9-F6D8-429E-8D02-1C52855B9F08

Q33377664-816036ED-4A3F-4FAA-B255-8C6D3C62C107

Q33377664-8175B1A2-AF9F-466B-AE09-C7E69B610D99

P2860

Q33377664-02B1EBF1-F5E1-4EE7-9EEE-C25C5030A61A

Q33377664-02E7854C-04D7-42F3-8FA1-B7A26FD77BD4

Q33377664-1DAE9848-054C-43A0-856F-A19F3CB98E20

Q33377664-1E77D970-43F1-4D99-86F0-A17DBE00456F

Q33377664-2A2067E7-7FEE-409B-B4D5-AC8ADAC3FD5F

Q33377664-32B6C908-35C4-4058-A2F8-11E563C18880

Q33377664-33D10E9D-9D90-4D63-B2A5-BFBA2F262711

Q33377664-36B041D8-E729-4462-8557-00CF7B9B79A3

Q33377664-3B582E6F-3B8C-4D6C-BD47-8785A29A28A8

Q33377664-3BAE28BD-CB6D-4CF0-94E5-9B6319F3625D

P304

Q33377664-C29D4EC7-93DF-401F-ADAE-697CB40D55A1

P31

Q33377664-67F62D5A-26D1-43A4-A065-C90C456582D0

P356

Q33377664-7395E33E-5270-4C3A-BC8D-265E0CDAFDF5

P407

Q33377664-12F91113-B4C7-4E6C-98CD-556D2C7E8FBA

P433

Q33377664-2BF4182A-64DF-4480-A2CC-0EA44E2EC0E9

P478

Q33377664-6950544C-810E-44CA-8544-4A9258EBD1F3

P50

Q33377664-3A19A127-3765-44DF-92EF-BB34C59A0A7A

P577

Q33377664-E12BE9F8-9968-4E5B-BC1A-9D35E85E8AE5

P698

Q33377664-D9F1A20E-804A-456D-83C2-5978FA6323A2

P932

Q33377664-F12230F2-F9F4-405E-8673-3A502CF9274C

P356

1078-0432.CCR-07-0874

P1433

Clinical Cancer Research

P1476

Phase I study of temozolomide ...... n brain tumor consortium study

@en

P2093

Frank Lieberman

http://www.w3.org/2001/XMLSchema#string

Howard Fine

http://www.w3.org/2001/XMLSchema#string

Ian H Robins

http://www.w3.org/2001/XMLSchema#string

John Kuhn

http://www.w3.org/2001/XMLSchema#string

Karen L Fink

http://www.w3.org/2001/XMLSchema#string

Kathleen Lamborn

http://www.w3.org/2001/XMLSchema#string

Kenneth D Aldape

http://www.w3.org/2001/XMLSchema#string

Larry Junck

http://www.w3.org/2001/XMLSchema#string

Michael D Prados

http://www.w3.org/2001/XMLSchema#string

Minesh Metha

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma.

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: a report from the Children's Cancer Group.

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

P304

7133-7138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-0874

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Lisa M DeAngelis

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18056194

http://www.w3.org/2001/XMLSchema#string

P932

4802002

http://www.w3.org/2001/XMLSchema#string